RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+17.22%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.6B
AUM Growth
+$258M
(+11%)
Cap. Flow
+$1.53M
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
27.05%
Holding
158
New
8
Increased
60
Reduced
23
Closed
11
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$21.9M |
| 2 |
UnitedHealth
UNH
|
$19.6M |
| 3 |
West Pharmaceutical
WST
|
$15.9M |
| 4 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$12.8M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$11.2M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$41.1M |
| 2 |
AET
Aetna Inc
AET
|
$40.4M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$23.5M |
| 4 |
Prothena Corp
PRTA
|
$11.7M |
| 5 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$9.97M |
Sector Composition
| 1 | Healthcare | 89.32% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Puma Biotechnology
PBYI
$253M
| $28.1M | 1.08% |
475,800
+62,900
| +15% | +$3.72M |
|
|
TSRO
27
DELISTED
TESARO, Inc.
TSRO
| $27.8M | 1.07% |
625,400
+52,400
| +9% | +$2.33M |
|
28
Axogen
AXGN
$735M
| $27.4M | 1.05% |
545,000
+40,000
| +8% | +$2.01M |
|
|
PRAH
29
DELISTED
PRA Health Sciences, Inc.
PRAH
| $26.9M | 1.04% |
288,247
-106,753
| -27% | -$9.97M |
|
|
WMGI
30
DELISTED
Wright Medical Group Inc
WMGI
| $26M | 1% |
1,000,000
| – | – |
|
31
Gilead Sciences
GILD
$143B
| $25.9M | 1% |
365,000
+51,600
| +16% | +$3.66M |
|
|
MDCO
32
DELISTED
Medicines Co
MDCO
| $25.3M | 0.97% |
690,000
| – | – |
|
33
Teleflex
TFX
$5.78B
| $24.8M | 0.95% |
92,500
| – | – |
|
|
ALDR
34
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $24.7M | 0.95% |
1,565,000
+35,200
| +2% | +$556K |
|
35
Edwards Lifesciences
EW
$47.5B
| $24M | 0.92% |
495,000
-75,003
| -13% | -$3.64M |
|
36
Exact Sciences
EXAS
$10.2B
| $22.7M | 0.87% |
380,000
+9,500
| +3% | +$568K |
|
37
Align Technology
ALGN
$10.1B
| $22.6M | 0.87% |
66,000
+500
| +0.8% | +$171K |
|
38
Inogen
INGN
$219M
| $22.2M | 0.85% |
119,000
+8,500
| +8% | +$1.58M |
|
39
Baxter International
BAX
$12.5B
| $21.9M | 0.84% |
297,000
| – | – |
|
40
Heron Therapeutics
HRTX
$201M
| $20.4M | 0.78% |
525,000
+49,000
| +10% | +$1.9M |
|
41
Thermo Fisher Scientific
TMO
$186B
| $19.9M | 0.77% |
96,000
-18,500
| -16% | -$3.83M |
|
42
Incyte
INCY
$16.9B
| $19.8M | 0.76% |
296,000
+113,500
| +62% | +$7.6M |
|
43
Insmed
INSM
$30.7B
| $19.5M | 0.75% |
825,000
| – | – |
|
|
NUVA
44
DELISTED
NuVasive, Inc.
NUVA
| $19.4M | 0.75% |
372,500
+67,500
| +22% | +$3.52M |
|
45
FibroGen
FGEN
$48.9M
| $19.2M | 0.74% |
12,280
-100
| -0.8% | -$156K |
|
46
Cencora
COR
$56.7B
| $18.8M | 0.72% |
220,000
-75,000
| -25% | -$6.4M |
|
47
Zimmer Biomet
ZBH
$20.9B
| $17.9M | 0.69% |
165,830
+13,905
| +9% | +$1.5M |
|
48
Mersana Therapeutics
MRSN
$34M
| $17.9M | 0.69% |
40,000
-12,000
| -23% | -$5.36M |
|
49
Assembly Biosciences
ASMB
$183M
| $17.6M | 0.68% |
37,500
+583
| +2% | +$274K |
|
50
Aclaris Therapeutics
ACRS
$227M
| $17.1M | 0.66% |
856,000
+326,000
| +62% | +$6.51M |
|